The Medicaid Managed Care Rule (Final Rule) finalizes several new and updated standards to support and improve managed care accessibility, finance, and quality in Medicaid and the Children’s Health Insurance Program (CHIP). Recently released by the Centers for Medicare &
The new Medicaid Managed Care Final Rule (Final Rule), recently released by the Centers for Medicare and Medicaid Services (CMS), makes significant changes to state directed payments. The provisions in the Final Rule aim to enhance transparency and consistency in
Children are generally recognized by both industry and government to be a vulnerable or special audience when it comes to advertising. On June 28, 2023, a new advertising code will be coming into effect as released by Ad Standards Canada.
Children are generally recognized by both industry and government to be a vulnerable or special audience when it comes to advertising. On June 28, 2023, a new advertising code will be coming into effect as released by Ad Standards Canada.
The US is approaching 7,000 cases, the largest number of any country around the world. Of concern to the Administration is the nearly 80 percent increase in cases over the last 7 days. Of equal concern is the lack of
Between 60 to 75 percent of new COVID-19 diagnoses are now said to be attributed the BA.5 variant. Health officials have advised anyone who has not had a second booster to do so now, with fears that existing immunity could
Today, President Biden announced that one million persons have died in the United States due to Covid. Unfortunately, deaths from Covid-19 are on the rise again sparked by Omicron variants. The data on new cases are getting less reliable due
On April 19, 2022, a federal district court in Florida determined the federal mask mandate from the Biden Administration was unlawful and therefore void. The mandate required patrons to wear a mask on public transportation, like airplanes, trains, and buses.
Yesterday, March 29, 2022, the CDC launched a new calculator designed to help individuals exposed to COVID-19 discern how many days of quarantine and/or isolation are necessary. This tool was created in order to aid in the prevention of spreading
The High Court has delivered the latest instalment in Lundbeck and Sandoz’s lengthy saga concerning escitalopram. The particular circumstances giving rise to this dispute are unique, however, the High Court’s approach to interpreting a patent licence granted by